ARSUF (Fagron) Short Interest


ARSUF Fagron SA ARSUF
92 GF Score
Price $26.53
GF Value $25.96
! 6 Warning Signs
View Full Analysis

What is Fagron Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ARSUF vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fagron's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fagron Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fagron's Short Interest distribution charts can be found below:

* The bar in red indicates where Fagron's Short Interest falls into.


ARSUF
92GF Score
Fagron SA ARSUF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fagron (ARSUF) Overvalued in 2026?

Based on GuruFocus' analysis, Fagron stock appears to be overvalued. The current stock price of $26.53 is trading 2.2% above its estimated GF Value™ of $25.96.

Key valuation signals for ARSUF:

  • Short Interest:
  • GF Value™: $25.96 vs. price of $26.53 (2.2% above fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the ARSUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fagron Business Description

Address Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a Belgium-based multinational pharmaceutical compounding company specializing in pharmaceutical compounding. It operates across the pharmaceutical compounding value chain, developing and manufacturing personalized medicines in collaboration with pharmacists, prescribers, hospitals, and other healthcare providers. The company has three segments: Essentials, Brands, and Compounding Services. The majority of the revenue is derived from the Essentials segment, which provides raw materials, equipment, packaging, and supplies for compounding to pharmacies and healthcare industries across EMEA, Latin America, and North America - Pacific. Geographically, it generates the maximum revenue from Fagron North America - Pacific.
92GF Score

Get the complete analysis for ARSUF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.53
Price
$25.96
GF Value